Tikun Olam

Tikun Olam, meaning "Repair the World" in Hebrew, began as a nonprofit in 2005 when founder Tzahi Cohen recognized the need for legitimate medical cannabis access in Israel. The company started out as a non-profit in 2005. Then, after regulation in 2010, the company became a limited company following Israel's Ministry of Health cannabis regulations.The company's breakthrough came in the middle of 2012 when it was able to develop a unique strain of medical marijuana that does not contain the psychoactive substance THC, producing no sense of intoxication, and yet had anti-inflammatory properties of the plant called cannabidiol, or CBD. This revolutionary high-CBD strain, Avidekel, earned global recognition as the world's first "highless marijuana" and established Tikun Olam as a pioneer in medical cannabis research.With more than 15 years of clinical and laboratory experience, the company has expanded internationally with operations in Canada, the United States, Europe, and Asia. The company was awarded ISO 9001 accreditation for the growing, production, sale and distribution of medical grade cannabis, as well as, patient instruction and care in 2012. Today, Tikun Olam operates as a global pharmaceutical company with one of the world's largest medical cannabis patient databases.

Tikun products are available exclusively at Vidacann dispensaries in the state of Florida following their partnership established in 2019. Planet 13 Holdings on Monday announced a $48.9 million deal to acquire Florida-based VidaCann's vertically integrated marijuana operation, which includes 26 medical cannabis dispensaries, expanding access to Tikun's products across the state.The brand offers a comprehensive product portfolio including flower, vape cartridges, tinctures, topicals, and edibles. Tikun's proprietary strains include Avidekel (high-CBD, non-intoxicating), Erez (powerful pain relief), Midnight (balanced 1:1 THC:CBD), Alaska (uplifting sativa), and Eran Almog (sedative indica). Each strain has been specifically developed through extensive clinical research to target different medical conditions and symptoms.The company's pharmaceutical products provide support in serious diseases: Cancer, Multiple Sclerosis, HIV, Hepatitis C and maintains EU-GMP certification for strict quality control. Tikun Olam Europe's signature medical cannabis is cultivated using exclusively high-level scientific techniques. It features the exclusive use of cannabis strains that have been genetically modified for maximum effectiveness in symptomatic relief.

Tikun Olam's mission centers on their Hebrew name's meaning: "Repair the World." The company's founding vision continues to drive us to work hard to provide patients with unparalleled treatment alternatives through the development of industry-leading professional standards for growing and treating patients with the highest quality medical grade cannabis available.Tikun Olam believes that an integral part of medical cannabis treatment is empowering patients with access to the professional knowledge to effectively and safely choose and consume the right dose and the right variety customized per patient. The company established the world's first nurse clinic where registered nurses guide patients throughout their treatment journey.In accordance with the company's mission to provide treatment for special and vulnerable population segments, we've developed unique products especially for sick children that are easily and safely administered. Their commitment extends to elderly patients, pioneering treatments at nursing homes and conducting groundbreaking research on pediatric applications, particularly for autism and epilepsy.